ZA201500254B - Status of tuberculosis infection in an individual - Google Patents

Status of tuberculosis infection in an individual

Info

Publication number
ZA201500254B
ZA201500254B ZA2015/00254A ZA201500254A ZA201500254B ZA 201500254 B ZA201500254 B ZA 201500254B ZA 2015/00254 A ZA2015/00254 A ZA 2015/00254A ZA 201500254 A ZA201500254 A ZA 201500254A ZA 201500254 B ZA201500254 B ZA 201500254B
Authority
ZA
South Africa
Prior art keywords
status
individual
tuberculosis infection
tuberculosis
infection
Prior art date
Application number
ZA2015/00254A
Other languages
English (en)
Inventor
Della Bella Chiara
M Delios Mario
Singh Mahavir
Original Assignee
Lionex Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lionex Gmbh filed Critical Lionex Gmbh
Publication of ZA201500254B publication Critical patent/ZA201500254B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/55IL-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/906Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/90605Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
    • G01N2333/90611Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1) in general
    • G01N2333/90616Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1) in general with a definite EC number (1.4.1.-)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA2015/00254A 2012-07-16 2015-01-14 Status of tuberculosis infection in an individual ZA201500254B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12176506.9A EP2687848A1 (en) 2012-07-16 2012-07-16 Status of tuberculosis infection in an individual
PCT/EP2013/065002 WO2014012928A1 (en) 2012-07-16 2013-07-16 Status of tuberculosis infection in an individual

Publications (1)

Publication Number Publication Date
ZA201500254B true ZA201500254B (en) 2016-06-29

Family

ID=48795573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/00254A ZA201500254B (en) 2012-07-16 2015-01-14 Status of tuberculosis infection in an individual

Country Status (13)

Country Link
EP (2) EP2687848A1 (enExample)
CN (1) CN104541169B (enExample)
AU (1) AU2013292040B2 (enExample)
CA (1) CA2878497C (enExample)
DK (1) DK2872896T3 (enExample)
EA (1) EA030721B1 (enExample)
ES (1) ES2666073T3 (enExample)
IN (1) IN2015MN00140A (enExample)
NO (1) NO2872896T3 (enExample)
PL (1) PL2872896T3 (enExample)
PT (1) PT2872896T (enExample)
WO (1) WO2014012928A1 (enExample)
ZA (1) ZA201500254B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3171170A1 (en) * 2015-11-17 2017-05-24 Lionex GmbH Device for use in elispot
KR20180104038A (ko) * 2016-01-20 2018-09-19 시아먼 유니버시티 활동성 결핵의 진단을 위한 방법 및 키트
CN106501530A (zh) * 2017-01-05 2017-03-15 复旦大学附属华山医院 一种诊断结核杆菌感染的生物标志物及其相关试剂盒
RU2726789C1 (ru) * 2020-01-17 2020-07-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ иммунологического определения активности туберкулезной инфекции у детей и подростков с латентной инфекцией
CN115598353B (zh) * 2022-10-24 2024-09-13 首都医科大学附属北京胸科医院 细胞因子作为标记物在制备肺外结核诊断或治疗预后产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) * 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
CA2279255A1 (en) 1997-01-29 1998-08-20 Flohe, Leopold Test kit for tuberculosis diagnosis by determining alanine dehydrogenase
JP5017269B2 (ja) * 2005-07-26 2012-09-05 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール
DE102007052518A1 (de) * 2007-10-29 2009-04-30 Autoimmun Diagnostika Gmbh Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen
CN102033129A (zh) * 2009-09-29 2011-04-27 上海英伯肯医学生物技术有限公司 用抗原刺激的细胞免疫反应来检测病原微生物的方法及测试笔

Also Published As

Publication number Publication date
WO2014012928A1 (en) 2014-01-23
EP2687848A1 (en) 2014-01-22
AU2013292040B2 (en) 2018-07-12
CN104541169A (zh) 2015-04-22
NO2872896T3 (enExample) 2018-05-26
PL2872896T3 (pl) 2018-08-31
DK2872896T3 (en) 2018-04-09
EA201590220A1 (ru) 2015-06-30
PT2872896T (pt) 2018-04-02
CA2878497C (en) 2021-06-08
EP2872896B1 (en) 2017-12-27
ES2666073T3 (es) 2018-04-30
EP2872896A1 (en) 2015-05-20
CA2878497A1 (en) 2014-01-23
EA030721B1 (ru) 2018-09-28
IN2015MN00140A (enExample) 2015-10-16
CN104541169B (zh) 2017-09-15
AU2013292040A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamars and their uses
IL233051B (en) Anti-phf-tau antibodies and uses thereof
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
IL229844B (en) Anti-psgl-1 antibodies and their use
IL237926A0 (en) Combinations and their uses
EP2825647A4 (en) METHODS OF GENE REARRANGING
GB201110783D0 (en) Methods and uses
GB201216649D0 (en) Agents and methods
GB201513279D0 (en) Micro-evolution of microbes
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
GB201116774D0 (en) Uses and methods
EP2716359A4 (en) COMPLEX AND USES THEREOF
ZA201500254B (en) Status of tuberculosis infection in an individual
SG11201504482VA (en) Beta-hexosyl-transferases and uses thereof
GB2498454B (en) Improvements in accelerometers
GB201108490D0 (en) Methods and uses
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
PL2895176T3 (pl) Związek pośredni Rywaroksabanu i jego wytwarzanie
IL238863A0 (en) Laminating device and use of laminating device
GB201211961D0 (en) Methods and groups
GB201208845D0 (en) Methods and groups
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder